Ultralife Corp. (ULBI) Tops Q2 EPS by 27c

Ultralife Corp. (NASDAQ: ULBI) reported Q2 EPS of $0.29, $0.27 better than the analyst estimate of $0.02. Revenue for the quarter came in at $42.7 million versus the consensus estimate of $33 million.

For earnings history and earnings-related data on Ultralife Corp. (ULBI) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• The free USDA tool that tracks egg prices at $0.62/dozen before your data vendor does
• Prenetics Global (PRE) Tops Q2 EPS by 18c